Lilly(Eli) & Co LLY: $245.05

Lilly Corporate Ctr, Indianapolis, Indiana, US. | Sector: Manufacturing | Exchange: NEW YORK STOCK EXCHANGE INC. | Web: www.lilly.com

  • Market Cap$233.76B
  • Change (52 Weeks)74.12%
  • Low (52 Weeks)$127.04
  • Insider Activity


    Bought Shares
    The Insiders have bought 18,502,750 shares in the last 6 months.

    Insider Activity of Last 6 Months


    Title
    Name
    Total Bought
    Total Sold
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    Chief Accounting OfficerHANISH ARNOLD C16,748-11,113
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres.-Emerging Markets BUTapiero Jacques14,882
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Chief Accounting OfficerHANISH ARNOLD C16,748-11,113
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    EVP, Science and TechnologyPAUL STEVEN M512,985-331,174
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    PRENDERGAST FRANKLYN G32,324
    President and COOLECHLEITER JOHN C155,390-76,666
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP & CIDORau Diogo20,160
    GILMAN ALFRED G25,494
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP & CIDORau Diogo20,160
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    Baicker Katherine19,411
    SVP, CSO, and Pres. LRLSkovronsky Daniel110,557
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    President and COOLECHLEITER JOHN C155,390-76,666
    President, U.S. OperationsConnelly Deirdre P25,625
    President, Lilly USAConnelly Deirdre P46,301-10,357
    Senior VP, Human ResourcesMahony Susan18,370-1,906
    President, Lilly USAConnelly Deirdre P46,301-10,357
    Smiley Joshua L25,409
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP, CSO, and Pres. LRLSkovronsky Daniel110,557
    SVP & Pres-Lilly OncologyWhite Anne E.51,490-3,306
    Chief Accounting OfficerHANISH ARNOLD C16,748-11,113
    COOK J MICHAEL7,353
    President, Lilly USAConnelly Deirdre P46,301-10,357
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP, CSO, and Pres. LRLSkovronsky Daniel110,557
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres, LillyDiab & LillyUSAConterno Enrique A240,130-98,922
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    HOOVER R DAVID31,651
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP & CIDORau Diogo20,160
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    Senior VP, Global QualityNorton Johna40,375-12,996
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP & CIDORau Diogo20,160
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres.,Elanco Animal HealthSimmons Jeffrey N129,023-32,056
    GILMAN ALFRED G25,494
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres., Lilly Bio-MedsShaw Christi68,750-43,003
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP, CSO, and Pres. LRLSkovronsky Daniel110,557
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    Chairman, President, and CEOLECHLEITER JOHN C2,148,135-851,660
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    Senior VP, Global QualityNorton Johna40,375-12,996
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Sr. VP and General CounselARMITAGE ROBERT A537,937-393,130
    Senior VP, Global QualityNorton Johna40,375-12,996
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    Chief Accounting OfficerZakrowski Donald A43,647-24,540
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    President and COOLECHLEITER JOHN C155,390-76,666
    HOOVER R DAVID31,651
    Chief Accounting OfficerHANISH ARNOLD C16,748-11,113
    President and COOLECHLEITER JOHN C155,390-76,666
    Chief Accounting OfficerHANISH ARNOLD C16,748-11,113
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    SVP and Pres, Lilly Bio-MedsRicks David A170,728-40,846
    HORN KAREN N29,434
    SVP, CSO, and Pres. LRLSkovronsky Daniel110,557
    EVP and Pres, Est Markets BUCarmine Bryce D.189,565-19,173
    Chairman, President, and CEOLECHLEITER JOHN C2,148,135-851,660
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    President and COOLECHLEITER JOHN C155,390-76,666
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362
    SVP&Pres., Emerging MarketsTapiero Jacques186,567-87,362

    What is Insider Activity?

    Insider activity refers to company insiders, usually top order executives and directors, buying and selling shares of the company.

    The legendary investment manager, Peter Lynch once said, "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”

    When insiders (Directors, CEO, CTO and other top-level executives) of a company are buying shares, it provides more confidence for Outsiders (Traders) to speculate that the company’s stock price might increase, which leads them to take more buy positions, driving the share value higher.

    Latest News About Lilly(Eli) & Co